AIM2 and neoplasm: Furthermore, AIM2 has been demonstrated to facilitate the transition of tumor-associated macrophages (TAMs) from an anti-inflammatory M2-type to a pro-inflammatory M1-type by activating inflammasome signaling, thereby promoting tumor rejection and impeding tumor cell proliferation16.